Chiara Cerrato
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CD38 as an immunotherapeutic target in multiple myeloma.
Journal: Expert opinion on biological therapy
Published: November 06, 2018
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 06, 2018
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis.
Journal: Journal of cancer research and clinical oncology
Published: December 27, 2017
Plasma cell leukemia: update on biology and therapy.
Journal: Leukemia & lymphoma
Published: November 08, 2016
New pharmacotherapy options for multiple myeloma.
Journal: Expert opinion on pharmacotherapy
Published: December 20, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 19, 2015
Autologous transplantation and maintenance therapy in multiple myeloma.
Journal: The New England journal of medicine
Published: September 04, 2014
Optimal management of elderly patients with myeloma.
Journal: Expert review of anticancer therapy
Published: December 07, 2013
Initial treatment of nontransplant patients with multiple myeloma.
Journal: Seminars in oncology
Published: October 19, 2013
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.
Journal: American journal of hematology
Published: August 01, 2013
The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma.
Journal: Expert opinion on drug metabolism & toxicology
Published: July 10, 2013
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Journal: Haematologica
Published: March 01, 2013
Last Updated: 09/26/2026